CRC 12046: A Randomized Study of Palifosfamide-tris in Combination with Carboplatin and Etoposide (PaCE) Chemotherapy vs Carboplatin and Etoposide (CE) Alone in Chemotherapy Naive Patients with Extensive-Stage Small Cell Lung Cancer
- Type of Study
- Cancer (Oncology) - Lung
- Location
- Swedish Cancer Institute
- Short Description
Purpose: This is a multinational, multicenter, randomized controlled, open-label, adaptive study to evaluate the efficacy of PaCE chemotherapy in chemotherapy naive subjects with extensive-stage SCLC
- Status
- Temporarily Closed
- Principal Investigator
- Howard (Jack) West, M.D.
- Eligibility Notes
- Documented extensive-stage small cell lung cancer
- Patient has received no prior chemotherapy, adjuvant therapy, or radiotherapy for lung cancer
- ECOG Performance Status of 0, 1 or 2
- No previously untreated (non-irradiated), symptomatic brain metastases
- More Info Link
- Additional information about the study summary and eligibility criteria may be viewed on the U.S. National Institutes of Health (NIH) website.
- Phone
- (206) 215-3086
- CancerResearch@swedish.org
